Figure 4.
![Figure 4. Comparative activities of A24, AZT, IFN-α, VP16, and Ars on the proliferation of tumor cells. Tumor cells from a patient with chronic ATL were incubated with or without A24 and treated with or without different chemotherapeutic agents such as AZT, IFN-α, or both AZT and IFN-α, Ars, or VP16 for 72 hours to determine the potential synergistic effect of these agents with A24. Cells were pulsed with [3H]-thymidine and harvested, before measuring the incorporation of [3H]-thymidine. Data are means ± SD of one representative experiment of 3 separate experiments.](https://ash.silverchair-cdn.com/ash/content_public/journal/blood/103/5/10.1182_blood-2003-07-2440/6/zh80050457650004.jpeg?Expires=1735580382&Signature=zXCAThf7LPg~gg9kceAuRKQlsko4M0Eb-rMyw3m-DA51rD4tUkR4GLDy8ucRN~dKHv7Mh71Q5zKPDICyU3Hj9tJEGtQbL38DTbTLYaWhjuPRb~sxK42dj5AcPSWqrOhS3w21bwCsZ2IwS36ZIIuHzV1l93Bp~YnzD4xZLBZTuZ4VzD6Jw0p5i5Gf99iRlAIFP2wOm9I~UXcSw0pwI687rqb0An7~A6inNybn4LOF7MSJHxkrpVQndvpa2oDyheE4k9-vkn8vMTx0K4iwq3Y1SAUlFPG379w8avKc3c14lsagJP3jpUyAVzgRAti7NM8uCjo5ueW-YuHcX56Vr7pNSA__&Key-Pair-Id=APKAIE5G5CRDK6RD3PGA)
Comparative activities of A24, AZT, IFN-α, VP16, and Ars on the proliferation of tumor cells. Tumor cells from a patient with chronic ATL were incubated with or without A24 and treated with or without different chemotherapeutic agents such as AZT, IFN-α, or both AZT and IFN-α, Ars, or VP16 for 72 hours to determine the potential synergistic effect of these agents with A24. Cells were pulsed with [3H]-thymidine and harvested, before measuring the incorporation of [3H]-thymidine. Data are means ± SD of one representative experiment of 3 separate experiments.
